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1. Introduction 
In animal cells as well as in microorganisms the 
intracellular levels of most amino acids are regu- 
* To whom cor respondence  should  be addressed.  
Abbrev ia t ions :  AIB, 2 amino i sobu ty r i c  acid; MeAIB,  2-methyl-  
amino i sobu ty r i c  acid; BCH, 2-aminobicyclo-[2,2,1]-heptane-2- 
carboxyl ic  acid;  CHO,  Chinese  hams te r  ovary. 
lated to meet t tutritional requirements of the 
cells. The amil ~ acid levels are maintained by 
balancing the uptake of amino acids from the 
extracellular medium, and the biosynthesis of cer- 
tain of the amino acids, with the needs of the cell 
for amino acids for protein synthesis and energy 
metabolism. The uptake of the neutral amino acids 
in animal tissues is carried out by several distinct 
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transport systems, which differ in their reactivities 
with substrates, ions, and inhibitors. Although the 
transport systems have been examined kinetically 
in a great many tissues and cell types, only fairly 
recently have these studies included the characteri- 
zation of the regulation of transport. Transport 
activity in animal cells has been shown to be 
affected, for example, by the cell density [1-4], the 
position in the cell cycle [4], and viral transforma- 
tion [1,3,5]. In this article, however, we will con- 
sider first the characterization of the neutral amino 
acid transport systems in mammalian cells, and 
then review some of the recent research on the 
regulation of the activities of these transport sys- 
tems by nutrient availability and hormones. 
II. Characterization of neutral amino acid transport 
systems in animal cells 
The uptake of neutral amino acids by animal 
cells is divided among a few transport systems that 
have overlapping substrate reactivities. Largely on 
the basis of the pattern of competitive interactions 
between neutral amino acids, Oxender and Chris- 
tensen [6] proposed the existence of two distinct 
routes of amino acid uptake in the Ehrlich ascites 
tumor cell. These were termed transport System A 
and transport System L. 
System A is most reactive with amino acids 
having short, polar, or linear side chains, such as 
alanine, glycine, and the nonmetabolizable analog 
2-aminoisobutyric acid (AIB) and its N-methyl- 
ated derivative, 2-methylaminoisobutyric acid 
(MeAIB). Transport by System A is sodium ion- 
dependent and is greatly reduced at lowered ex- 
tracellular pH. Uptake of amino acids by System 
A is often subject to trans-inhibition by intracellu- 
lar substrates of this system. System L is most 
reactive with branched-chain and aromatic amino 
acids, such as leucine, isoleucine, valine, phenyl- 
alanine, and the nonmetabolizable analog 2- 
aminobicyclo-[2,2,1]-heptane-2-carboxylic acid 
(BCH). Transport by System L is sodium ion-inde- 
pendent and in some cases is even stimulated by 
lowered extracellular pH. Uptake by System L is 
trans-stimulated by intracellular substrates of this 
system. Amino acid transport systems correspond- 
ing to Systems A and L have been described in a 
wide variety of animal cell types, including cells of 
avian and mammalian origin (for a listing, see Ref. 
7). 
A second sodium-dependent transport system 
was later characterized in the Ehrlich cell [8]. This 
system, which was more or less restricted in reac- 
tivity to alanine, serine, and cysteine, was termed 
System ASC. In addition to its substrate prefer- 
ence, System ASC is distinguished from System A 
on the basis of its relative pH-insensitivity, higher 
stereospecificity, intolerance of N-methylated sub- 
strates, and ability to be trans-stimulated by in- 
tracellular amino acids. Although it is a minor 
component in the Ehrlich cell, System ASC was 
shown to be a prominent system in the rabbit 
reticulocyte [9] and pigeon erythrocyte [10], cells in 
which System A activity is difficult to evaluate. 
System ASC is also more prominent and has a 
broader substrate reactivity in the rat hepatocyte 
[11], cultured human fibroblast [12,13], and 
Chinese hamster ovary cell [14,15]. 
There have been reports of additional sodium- 
dependent neutral amino acid transport systems 
that are apparently present in only one or a few 
cell types and often have a narrow range of sub- 
strates. System Gly, specific for glycine and its 
N-methylated derivative, sarcosine, was first de- 
scribed in the pigeon erythrocyte [16,17] and rab- 
bit reticulocyte [10]. More recently it was detected 
in rat hepatocytes and the hepatoma cell line HTC 
[18]. Christensen [19] has suggested that System 
Gly is a variant of System A. 
A transport route serving for the uptake of 
r -amino acids has been characterized in the Ehrlich 
cell [20,21] and is also known to occur in other 
eukaryotic cells. Taurine, a slowly metabolized, 
naturally occuring r-amino acid, has served as an 
appropriate model substrate of this system. This 
system is sodium-dependent and has been termed 
System/3 [21]. 
Recently a sodium-dependent transport system 
restricted in reactivity to glutamine, aspargine, 
histidine, and a few synthetic analogs was de- 
scribed in cultured rat hepatocytes [22,23]. This 
uptake route was named System N for the nitro- 
gen-containing side chains of each of its sub- 
strates. In addition to its specificity, System N was 
distinguished from System A on the basis of its 
insensitivity to insulin and glucagon, and from 
System ASC on the basis of its increased activity 
following amino acid starvation [22]. System N 
activity has been shown to occur in fetal hepato- 
cytes and the hepatoma cell line H4-II-EC3 
(Vadgama, J.V. and Christensen, H.N., unpub- 
lished data), but not in Chinese hamster ovary 
cells (Shotwell, M.S. and Oxender, D.L., unpub- 
lished data), human fibroblasts, or rat intestinal 
segments (Kilberg, M.S., unpublished data). These 
results have led to the suggestion that System N is 
unique to the liver [24]. 
Consideration of the common structural fea- 
tures of preferred substrates of Systems A and L 
led Christensen to design and synthesize amino 
acid analogs that are not metabolized by eukaryotic 
cells and are restricted in entry as much as possi- 
ble to a single transport system. The analog MeAIB 
has been used as a System A-specific substrate 
[25], and the analog BCH has been similarly em- 
ployed for System L [26]. These two relatively 
system-specific model amino acids have been used 
as competitive inhibitors to discriminate among 
transport routes. The component of uptake of an 
amino acid that is sensitive to inhibition by excess 
MeAIB can be assigned to System A, and the 
BCH-inhibitable portion of uptake can be as- 
signed to System L. Christensen has thoroughly 
discussed the synthesis of these and other system- 
specific amino acid analogs [19,27]. AIB has often 
been used as a model substrate for System A, but 
because the uptake of AIB occurs by multiple 
transport systems in several cell types [14,15, 
28-32], it should not be identified solely with 
System A, unless that relation has been proved for 
a particular cell type. 
A persistent problem in the discrimination of 
transport systems by inhibition analysis has been 
in finding an appropriate model amino acid for 
System ASC. Cysteine appears to serve as a specific 
substrate in the rat hepatocyte [28], and threonine 
may serve as an appropriate substrate in HTC 
cells [29], but the lack of an acceptable model 
substrate for System ASC in other cell types com- 
plicates the characterization of this system in the 
presence of other neutral amino acid transport 
systems. In some cases, System ASC activity has 
been operationally defined as the sodium-depen- 
dent uptake of an amino acid that is not inhibited 
by excess MeAIB [14,15] or N-methylalanine [33], 
although kinetic criteria of identification have also 
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been applied [13]. More extensive discussions of 
the difficulty in distinguishing System ASC from 
System A have recently been reported [ 13,30]. 
Table I is a summary of the characteristics of 
the neutral amino acid transport systems in animal 
cells. 
III. Regulation of transport activity by amino acid 
availability 
111.4. Regulation of System A 
Animal cells adapt to changes in nutrient avail- 
ability by regulating the activities of their amino 
acid transport systems. Riggs and Pan [34], using 
immature rat uterus preparations, and Guidotti 
and co-workers [35], using chick embryo heart 
cells, first observed that incubation of certain tis- 
sues in amino acid-free medium for 3 to 5 h led to 
increased neutral amino acid transport. This re- 
sponse has been referred to as adaptive regulation 
or starvation-induced transport enhancement. The 
increased transport activity was identified with 
System A on the basis of its sodium ion depen- 
dence, pH sensitivity, and by inhibition analysis 
[34,36]. Several studies have shown that Systems 
ASC and L are not increased in activity by incuba- 
tion in amino acid-free medium [36-39]. The addi- 
tion of System A amino acids to the medium 
prevented the enhancement of System A activity, 
but typical substrates of System L did not [35]. 
Individual amino acids could suppress the System 
A transport, and AIB was particularily effective 
[35,36]. The starvation-induced transport was 
accompanied by an increase in the Vma x of uptake 
of amino acids by System A with no significant 
change in the K m of uptake [34,35,40]. These re- 
sults are consistent with an increase in the number 
of active System A transport carriers. Because the 
increased transport activity could still be observed 
in cells depleted of amino acids prior to uptake 
measurements, release from trans-inhibition was 
ruled out as a basis for the adaptive response to 
amino acid deprivation [35]. 
An examination of the relationship between 
amino acid transport and the supply of amino 
acids showed that System A activity varies in- 
versely with the concentration of System A amino 
acids in the culture medium [41]. Higher levels of 
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TABLE I 
CHARACTERISTICS OF THE NEUTRAL AMINO ACID TRANSPORT SYSTEMS IN ANIMAL CELLS 
A ASC Gly /3 N L 
1 .Cation-dependence sodium- sodium- sodium- sodium- sodium- sodium- 
dependent dependent dependent dependent dependent independent 
2.Substrate reactivity most, esp. Ala, Ser, Gly, sar- fl-Ala, Asn, Gin, most, esp. 
Ala, Gly, Cys a cosine taurine His Leu, lie, 
Pro, AIB Val, Phe 
3.Specific substrate MeAIB Cys, Thr b Gly taurine Gin BCH 
4 .  T r a n s  Effects t r a n s  - t r a n s -  ? ? ~ t r a n s  - 
inhibited stimulated stimulated 
5.Effect of low pH inhibited variable c none ? inhibited stimulated 
6.Stereospecificity moderate high --  '~ high moderate 
7.Regulation by amino acid limita- 
tion yes no no no yes yes d 
8.Hormonal regulation yes no no no no no 
9.Cell in which first described EATC e EATC pigeon EATC rat hepat- EATC 
erythrocyte ocyte 
10.Cell distribution most, not ubiquitous? pigeon EATC, rat rat hepat-  ubiquitous? 




a Broader substrate reactivity (including Thr, Leu, lie, and Phe) in rabbit ileum [57], Chinese hamster ovary cells [14,15], and rat 
hepatocytes [30]. 
b Cys in rat hepatocytes and intestinal epithelium [28], Thr in HTC cells [29], and both in H4-1I-EC3 cell (Vadgama, J.V. and 
Christensen, H.N., unpublished data). 
e Inhibited below pH 6.0 in HTC cells [29]; not inhibited in hepatocytes [22]. 
d Enhanced activity caused by leucine limitation in Chinese hamster ovary cells [52.53]; inverse changes in activity in two 
sodium-independent components, Systems LI and L2, in primary cultures of rat hepatocytes [54,55]. 
EATC, Ehrlich ascites tumor cell. 
substrates of System A in the growth medium thus 
lead to lower System A activities. 
The regulation of System A transport  activity 
by amino acid supply has now been described in 
many  tissue and cell types [7,37,42-47] including 
cells in culture [14,38,39,41,48,49]. 
The enhancement  in System A activity by star- 
vat ion for amino  acids apparent ly  requires synthe- 
sis of both R N A  and protein. Inhibi tors  both of 
t ranscr ipt ion and translat ion have been shown to 
prevent  this response in several cell types 
[14,34,35,38,39,43,45,50,51]. Guido t t i  and co- 
workers [50] showed that ac t inomycin D was inef- 
fective in prevent ing the increase in transport  when 
added after 90 min  of starvation, and suggested 
that increased t ranscr ipt ion occurs within 30 rain 
of starvation. In  contrast,  addi t ion of the protein 
synthesis inhibi tor  cycloheximide at times past 90 
min  blocked any further increase in t ransport  [50]. 
Guidot t i  and colleagues have concluded from their 
studies using inhibitors of macromolecular  synthe- 
sis that System A transport  activity is regulated by 
a repression-derepression mechanism acting at the 
t ranscript ional  level [7,50,51 ]. 
The reversal of the s tarvat ion-induced System 
A enhancement  by refeeding with amino acids was 
also found to require active RN A  and protein 
synthesis in both chick embryo fibroblasts [51] and 
cultured huma n  fibroblasts [50]. In the presence of 
a protein synthesis inhibitor,  the half-life of en- 
hanced System A transport  was found to be about  
200 min in chick embryo fibroblasts [51] and 
several hours in cultured huma n  fibroblasts [50]. 
In  both cell types the decay of the uptake to basal 
levels was accelerated by the addi t ion of System A 
amino  acids. These observations led Guidot t i  to 
propose a complex model involving a factor that 
degrades or inactivates System A activity follow- 
ing refeeding of starved cells with System A amino 
acids [50,51]. 
IIIB. Regulation of System L 
IllB-1. Kinetic approaches 
System L transport activity is also regulated in 
animal cells. Many of the early studies using several 
cell types showed that, in contrast to System A, 
System L is either unchanged or slightly decreased 
in activity following complete starvation for amino 
acids [36-39]. Adaptive increases in System L 
transport can, however, be easily observed in a 
temperature-sensitive leucyl-tRNA synthetase 
Chinese hamster ovary mutant, the CHO-tsH1 
line, when these cells are grown at marginally 
permissive temperatures [52,53], and also in 
primary cultures of rat hepatocytes [54,55]. 
The CHO-tsH1 mutant cell line has a tempera- 
ture-sensitive leucyl-tRNA synthetase and grows 
normally at 34°C, but cannot grow at 39°C. When 
CHO-tsH1 cells are incubated at 38°C, a tempera- 
ture at which the leucyl-tRNA synthetase is par- 
tially inactivated, the transport activity for leucine 
increases two- to threefold [52,53]. This temper- 
ature-dependent increase in leucine transport was 
shown to be restricted to System L on the basis of 
its sodium independence, substrate reactivity, and 
inhibition by BCH [53]. This transport enhance- 
ment is reflected by an increase in the Vma X of 
leucine uptake with no change in its K m of uptake 
[53]. These results are consistent with an increase 
in the number of System L transport carriers. 
The temperature-dependent elevation in System 
L activity in CHO-tsH1 cells could not be ex- 
plained by a trans-stimulation of System L by 
intracellular amino acids because cells depleted of 
amino acids prior to uptake measurements still 
showed increased transport [53]. The transport 
enhancement could be prevented by cycloheximide 
but not by actinomycin D, leading to the sugges- 
tion that System L may be regulated at the transla- 
tional level [53]. 
Increases in System L activity were also ob- 
served in nonmutant CHO cells, although it was 
necessary to incubate the cells in media containing 
very low concentrations of leucine and normal 
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levels of all other nutrients [53]. It was concluded 
that starving CHO cells for leucine, whether by 
incubating a temperature-sensitive leucyl-tRNA 
synthetase mutant at an elevated temperature, or 
by incubating nonmutant cells in very low levels of 
leucine, leads to increased amino acid transport 
activity by System L. The regulation of the activity 
of transport System L appears, therefore, to be 
linked to the availability of leucine for protein 
synthesis, and conceivably the signal for this 
leucine-dependent regulation may be the ratio of 
charged to uncharged tRNA Leu, rather than sim- 
ply the size of the intracellular pool of leucine. 
Although the adaptive regulation of System A 
and the leucine-dependent regulation of System L 
in animal cells are both adaptive responses leading 
to an increase in the activity of a single amino acid 
transport system, significant differences exist be- 
tween the two. First, System A derepression can be 
observed only after limitation of all of the System 
A amino acids, whereas System L is not elevated 
under these conditions. System L enhancements 
result from the deprivation of but a single System 
L amino acid, leucine. Second, the maximum in- 
crease in System A activity occurs much more 
slowly than that for System L. Whereas System A 
activity rises for 12 to 20 h of amino acid starva- 
tion [39,41], System L transport increases occur 
within the first 4 h of leucine limitation [53]. A 
third distinction is that the increased activity of 
System A is slowly reversed upon amino acid 
refeeding. This reversal requires 6 to 12 h [38,50], 
whereas the reversal of enhancement in System L 
activity is complete within 6 h after shifting CHO- 
tsH 1 cells from an elevated temperature back to a 
permissive temperature [53]. A final contrast is 
that whereas the derepression of System A is pre- 
vented by inhibitors both of transcription and 
translation [14,35,38,39,43,45,50,51], the System L 
enhancement in CHO-tsH1 cells is not dependent 
upon active RNA synthesis for the first 4 h [53]. 
Accordingly, it has been tentatively suggested that 
different sites of control exist for the two systems. 
System A may be regulated at the level of 
transcription [7,50] and System L at the level of 
translation [53]. 
Kinetic heterogeneity has been demonstrated 
for sodium-independent transport of BCH, histi- 
dine, leucine, and tryptophan in primary cultures 
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of rat hepatocytes [54,55]. On the basis of this 
kinetic analysis, inhibition analysis, and other 
criteria, it was concluded that there are at least 
two sodium-independent systems for neutral amino 
acid transport in cultured hepatocytes. These com- 
ponents, designated L1 and L2, exhibit marked 
changes in activity during the first 48 h after 
establishment of primary cultures [55]. The System 
L1 activity, characterized by K m values in the 
micromolar range, was almost undetectable in 
freshly isolated hepatocytes or in cells cultured for 
less than 6 h [55]. This activity increased signifi- 
cantly during the next 48 hours and continued to 
increase for at least 6 days. In contrast, uptake by 
System L2 was quite rapid in freshly isolated cells, 
but its activity declined during the first 48 h of 
culturing such that transport by System L1 pre- 
dominated. System L2 exhibits K m values in the 
millimol~r range, and the decrease in activity is the 
result of a lowering of the Vma x [54,55]. The factors 
controlling these changes in sodium-independent 
transport are not yet known, but the increase in 
System L1 activity is dependent on both RNA and 
protein synthesis. Furthermore, cell density may 
affect the rate at which these changes occur (Kil- 
berg, M.S., unpublished data). 
IIIB-2. Genetic approaches 
Recently temperature-resistant revertants were 
isolated from the CHO-tsH1 cell line that appear 
to be defective in the regulation of the activity of 
System L. These revertants grow normally at 39°C 
in reduced leucine medium, conditions lethal for 
the temperature-sensitive starting strain, CHO- 
tsHl. The revertants were found to have two- to 
threefold increased System L activity even when 
grown at 34°C. It was suggested that this constitu- 
tively high transport activity resulted from a muta- 
tional defect in the regulation of System L expres- 
sion in each revertant cell line (Shotwell, M.A., 
Collarini, E.J., Hampel, A.E. and Oxender, D.L., 
unpublished data). 
In a second genetic approach, another tempera- 
ture-sensitive leucyl-tRNA synthetase CHO 
mutant was fused with a human leukocyte to form 
interspecific hybrid cells [56]. Temperature-re- 
sistant hybrids were then selected for growth at 
38.5°C. In some of these temperature-resistant 
hamster-human strains the activity of transport 
System L was found to be elevated and to no 
longer respond to the growth temperature 
(Lobatrn, C.D. and Oxender, D.L., unpublished 
data). Segregation of human chromosomes from 
one of these high transport hybrids was then al- 
lowed. Karyotype analysis showed a correlation 
between the high transport phenotype and the 
presence of a single small human chromosome, 
which presumably carries a gene for leucine trans- 
port (Lobatrn, C.D. and Oxender, D.L., unpub- 
lished data). Efforts are underway to identify the 
human chromosome giving high leucine transport. 
I I IC Regulation of System N 
The activity of the recently characterized trans- 
port System N is regulated in cultured rat hepato- 
cytes [22], as well as in the hepatoma cell line 
H4-II-EC3 and normal fetal cells (Vadgama, J.V. 
and Christensen, H.N., unpublished data). The 
uptake of glutamine, taken as a model System N 
substrate, was increased about twofold after in- 
cubation of cultured hepatocytes in amino acid-free 
medium for 8 h [22]. This increased glutamine 
uptake was only partially inhibited by excess 
MeAIB, and was attributed therefore to System N 
instead of System A [22,23]. The adaptive increase 
in glutamine uptake was prevented by the addition 
to the starvation medium of one System N sub- 
strate, histidine, but not of two others, glutamine 
and asparagine [23]. Paradoxically, increased 
transport by System N was also largely eliminated 
by the addition of AIB, MeAIB, and cysteine, 
which are all neither substrates nor inhibitors of 
System N [23]. The protein synthesis inhibitor 
cycloheximide was also effective in preventing the 
starvation-induced glutamine transport enhance- 
ment in cultured hepatocytes, consistent with a 
role of protein synthesis in the regulation of Sys- 
tem N activity [23]. 
Although both are adaptive responses to amino 
acid deprivation, the starvation-induced enhance- 
ment of System N activity is relatively smaller 
than that of System A [22]. Nevertheless, even the 
two- to threefold increases in System N activity 
that have been observed would alter the flux of 
System N substrates considerably. The relevance 
of System N regulation to the metabolism of amino 
acids in the liver has yet to be established, how- 
ever. 
IV. Hormonal regulation of transport activity 
T h e  r egu l a t i on  o f  neu t r a l  a m i n o  ac id  t r a n s p o r t  
ac t iv i ty  r e v i e w e d  in  the  p r e c e d i n g  sec t ions  c o m -  
pr ises  a d a p t i v e  r e sponses  o f  i nd iv idua l  cel ls  to 
changes  in the  ava i l ab i l i t y  o f  n u t r i e n t  a m i n o  acids.  
H i g h e r  o r g a n i s m s  r equ i r e  a d d i t i o n a l  r e g u l a t o r y  
c o n t r o l  o f  a m i n o  ac id  t r a n s p o r t  in o r d e r  to ad jus t  
n u t r i e n t  f lows  b e t w e e n  the  d i f f e ren t  cell  types  in 
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e a c h  organ ,  as wel l  as b e t w e e n  the  d i f f e ren t  o rgans  
in  the  body .  C o n t r o l  b y  h o r m o n e s  is one  m e c h a -  
n i s m  by  wh ich  n u t r i e n t  f lows  a re  c o o r d i n a t e d  in 
the  mul t i - t i s sue  o rgan i sm.  T h e  h o r m o n a l  regula-  
t ion  o f  a m i n o  ac id  m e t a b o l i s m  can  be  d iv ided  in to  
th ree  phases :  (1) the  h o r m o n e - i n d u c e d  deg rada -  
t ion  of  p ro t e in  a n d  m o b i l i z a t i o n  o f  a m i n o  ac ids ;  
(2) the  h o r m o n e - s t i m u l a t e d  t r a n s p o r t  o f  a m i n o  
ac ids  in ta rge t  t issues;  and ,  (3) the  h o r m o n e - r e g u -  
TABLE II 
EFFECTS OF HORMONES, GROWTH FACTORS, AND CYCLIC AMP ON AMINO ACID TRANSPORT 
Much of the present information was obtained from previous reviews of this subject [7,58,59]. References that appear in this table are 
for reports not included in these previous reviews, or in some instances are for conflicting results with the same tissue. 





5. Epidermal growth factor (EGF) 
6. Estrogens 
7. Fibroblast growth factor (FGF) 
8. Follicle stimulating hormone (FSH) 
9. Glucagon 
10. Glucocorticoids 
11. Growth hormone 
12. Insulin 
13. Luteinizing hormone (LH) 
14. Multiplication-stimulating activity (MSA) 
15. Nerve growth factor (NGF) 
16. Parathyroid hormone (PTH) 




21. Thyroid stimulating hormone (TSH) 
22. Thyroid hormones 
Increased in adrenal gland, muscle, and intestine 
Decreased in kidney and adipose [158] 
Increased in prostate gland, seminal vesicles, skeletal muscle, and kidney 
Increased in liver [66,157], thymocytes, bond cells, 3T3 cells [ 150,159], and 
kidney [ 160] 
Decreased in adipose and kidney [ 161 ] 
Increased in liver, kidney, heart, muscle, and intestine 
Decreased in adipose and muscle 
Increased in chick embryo heart cells [162] and human fibroblasts [93] 
Increased in uterus and Ehrlich cells 
Increased in fibroblasts [94] 
Increased in ovaries and testes 
Increased in liver 
Decreased in adipose [161] 
Increased in liver [115,163] and fibroblasts 
Decreased in muscle, thymocytes, lymphocytes, mammary gland, HeLa 
cells, JTC-4 cells, L-929 cells, diaphragm, hepatomas [119], and normal 
liver [161,164] 
Increased in skeletal muscle, heart, liver [165], diaphragm, and adipose 
Increased in skeletal muscle, diaphragm, heart, liver, adrenal gland, bone, 
lymphocytes, uterus, adipose, fibroblasts, mammary [133], thyroid, retina 
[166], mammary adenocarcinoma [167], and lung [168] 
Decreased in kidney 
Increased in ovaries 
Increased in chick embryo heart cells and hepatoma cells [97,98] 
Increased in pheochromocytoma cells [96] 
Increased in bone, calvaria, and kidney cortex 
Increased in human diploid fibroblasts [95] 
Increased in intestine and mammary tissue 
Increased in thymocytes and bone 
Decreased in fibroblasts [169] 
Increased in cartilage, diaphragm, and fibroblasts [170] 
Increased in skeletal muscle, liver, and thyroid 
Increased in bone, cartilage, thymocytes, intestine [171], and liver [172] 
Decreased in pituitary 
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lated metabolism of the accumulated amino acids. 
In the following section we will review only the 
second phase of hormone regulation, the hormonal 
regulation of amino acid transport across the 
plasma membrane of mammalian cells. 
The effects of several classes of hormones have 
been reviewed elsewhere [7,24,58,59], and Table II 
is an updated summary of the hormonal control of 
amino acid transport. In most instances there is a 
correlation between the stimulation of amino acid 
uptake by a hormone in its specific target tissues 
and an increase in the anabolic activities of the 
cell, such as macromolecular synthesis, energy pro- 
duction, or cell division. Conversely, transport is 
either unaffected or inhibited when the effect of 
the hormone is catabolic, as in the case of gluco- 
corticoid inhibition of amino acid uptake in muscle 
[60,61]. 
Many of the early studies on hormonal regula- 
tion of amino acid transport were carried out 
using intact animals. When interpreting the results 
of these experiments, one must consider the possi- 
bility that exogenously administered hormones 
may cause the release of other hormones or growth 
factors that produce secondary effects. The devel- 
opment of in vitro culturing techniques for 
hormone-sensitive cells and organs has greatly 
aided the study of the primary effects of hormones 
on amino acid transport. 
From the hundreds of published studies on the 
hormonal regulation of amino acid transport, using 
a wide variety of cells and tissues, a few generali- 
zations have emerged. When the hormone-stimu- 
lated transport has been assigned to a particular 
transport system, System A has generally been 
found to be the hormone-sensitive system. A nota- 
ble exception is the work of Adamson and Ingbar 
[62,63] showing that the uptake of System L amino 
acids by cartilage tissue was increased by thyroid 
hormones more than the uptake of typical System 
A substrates. For the liver, three lines of evidence 
suggest that System A is the only amino acid 
transport system that responds to hormones. First, 
the transport system affected by hormones is 
sodium-dependent, ruling out the involvement of 
System L [64-67]. Second, the uptake of the Sys- 
tem A-specific amino acid MeAIB is stimulated by 
a wide variety of hormones in isolated hepato- 
cytes, as has also been seen in chick embryo heart 
cells [32,68] and rat diaphragm (Riggs, T.R., per- 
sonal cummunication). These observations do not 
rule out the possibility that sodium-dependent sys- 
tems other than System A are hormone-sensitive, 
but do demonstrate the hormone responsiveness of 
System A as assayed without interference from 
other transport agencies. Third, the hepatic trans- 
port Systems ASC [22], N [22], and L [62,66,69], as 
measured by the test substrates cysteine, gluta- 
mine, and BCH, respectively, all appear to be 
insensitive to hormones. 
Results from several laboratories suggest that 
the mechanism by which hormones stimulate 
amino acid transport includes an initial committed 
step after which the remaining steps can occur in 
the absence of the hormone. After a short ex- 
posure to insulin or glucagon, the continued pres- 
ence of the hormone is not necessary for the 
stimulation of transport to occur in isolated rat 
hepatocytes [70-72]. The increase in AIB uptake 
in hepatocytes placed in hormone-free medium 
after a 15-30-min treatment with either insulin or 
glucagon was about 60% of that seen when the 
hormone was present throughout. Even though 
about 80% of the cell associated insulin was re- 
leased during the 60-120 rain immediately after 
removal of the hormone-containing medium [71], 
the possibility exists that the binding of the 
hormone to its membrane receptor is the com- 
mitted step in this process. 
The relationship between glucagon receptor oc- 
cupancy and the degree of amino acid transport 
stimulation in rat hepatocytes appears to be non- 
linear; when only 5-20% of the glucagon receptors 
are filled, AIB uptake reaches 50% of its maximal 
stimulation. Moreover, 50% occupancy of the re- 
ceptors results in almost maximal rates of AIB 
uptake [73,74]. In contrast, studies involving the 
insulin induction of uptake suggested that insulin 
receptor occupancy and the degree of amino acid 
transport stimulation are nearly proportional 
[71,74]. Similar results have been obtained with rat 
thymocytes [75,76] and chick embryo heart cells 
[68]. Because the synthesis or activation of amino 
acid transport carriers may be several steps subse- 
quent to hormone binding, the significance of a 
lack of correlation between receptor occupancy 
and stimulation of transport by glucagon is un- 
clear. 
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IVA. Effect of down regulation on hormone-stimu- 
lated amino acid transport 
Prolonged exposure of cells to a hormone often 
leads to a decrease in the number of receptors for 
that hormone, a phenomenon referred to as down 
regulation [77,78]. A decrease in hormone binding 
should lead to a decrease in hormone-stimulated 
amino acid transport if the change in binding is 
within the concentration range affecting transport. 
For example, amino acid uptake in cultured hu- 
man fibroblasts is enhanced by treatment with 
insulin, but after a 4-day exposure to insulin the 
hormone concentration required to produce a 
stimulation of AIB uptake equal to that in un- 
treated cells is increased 30-fold [79]. 
A similar down regulation of insulin-stimulated 
amino acid transport may operate in the newborn 
rat diaphragm [80]. Insulin does not stimulate AIB 
transport in diaphragms from 1-day-old rats, al- 
though it does in diaphragms from older rats, even 
though the basal uptake rate is higher in the tissue 
from the younger animals. Because the plasma 
insulin levels of 1-day-old rats are five times those 
of 5-day-old animals, the decreased responsiveness 
to the hormone may result from exposure of the 
diaphragm to high concentrations of insulin. Riggs 
and co-workers [80] showed that artificially elevat- 
ing the plasma insulin levels of older rats resulted 
in a reduction in hormone sensitivity of the di- 
aphragm to a sensitivity similar to that in 1-day-old 
animals. 
Heaton and Gelehrter [81] showed that pro- 
longed exposure of the hepatoma cell line HTC to 
insulin led to complete hormone resistance as 
monitored by the stimulation of amino acid trans- 
p o r t  a n d  the  i n d u c t i o n  of  t y r o s i n e  
aminotransferase. They argued that this effect 
could not be a result of down regulation of insulin 
receptors on the basis of two findings. First, the 
usual loss of receptors during down regulation is 
generally only about 50-60% of the total, a reduc- 
tion insufficient to account for the total lack of 
response to the higher insulin concentrations tested 
in these studies. Second, after the hormone-re- 
sistant cells were washed to remove the bound 
insulin, full responsiveness to the hormone was 
regained within 2 h [81]. In support of the conclu- 
sions of Heaton and Gelehrter [81], Karlsson and 
colleagues [82] concluded that insulin resistance 
can result from control at steps subsequent to the 
hormone-receptor complex. 
The effect of growth hormone on AIB uptake in 
rat diaphragm is an example of the complex rela- 
tionship between age and the hormonal control of 
amino acid transport [83-89]. Diaphragms from 
rats 19 days old or younger showed a stimulation 
of amino acid uptake following treatment with 
growth hormone. Transport in diaphragms from 
older rats did not respond to the hormone, al- 
though the hormone sensitivity reappeared when 
these older animals were hypophysectomized 
[90,91]. The response of amino acid uptake by 
diaphragms from 15- to 19-day-old rats was bi- 
phasic with respect to the length of exposure to the 
hormone. A transient stimulation lasting from 1 to 
3 h was observed followed by a period of refracto- 
riness of up to 45 h [90,92]. During this refractory 
period the diaphragms of the younger rats resem- 
bled those of older animals in their insensitivity to 
growth hormone. This decrease in sensitivity was 
proposed to result from the action of an inhibitor 
of amino acid transport [84,92], although no such 
naturally occurring inhibitor has been isolated. 
The role of growth hormone receptors in this 
biphasic response has not yet been determined, 
although an initial hormonal stimulation of trans- 
port followed by a refractory period is consistent 
with control either by down regulation of growth 
hormone receptors, or by a post-receptor step as 
has been proposed for the insulin insensitivity in 
HTC cells described above. 
IVB. Effects of growth factors on amino acid trans- 
port activity 
Besides by hormones, amino acid transport ac- 
tivities are also affected by several types of growth 
factors isolated from serum (Table II), including 
epidermal growth factor [93], fibroblast growth 
factor [94], platelet-derived growth factor [95], 
nerve growth factor [96], and multiplication- 
stimulating activity [97,98]. As with hormones, the 
primary effect of each of these growth factors 
appears to be a stimulation of System A activity. 
For  nerve growth factor [96] and multiplication- 
stimulating activity [97] this System A enhance- 
ment was characterized by an increase in the Vma x 
of uptake with no change in the K m of uptake. 
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IVC. Role of cyclic AMP and calcium ion in the 
hormonal regulation of amino acid transport 
Conflicting conclusions have been drawn con- 
cerning the role of cAMP in the hormonal regula- 
tion of System A transport. From earlier studies 
with liver tissue it was concluded that cAMP 
mediates the glucagon induction of amino acid 
transport [66,99-101], based in part on the corre- 
lation seen between increases in cellular cAMP 
and increases in transport after glucagon treat- 
ment [102,103]. 
More recent results indicate that increases in 
cAMP may not be necessary for the stimulation of 
amino acid transport by glucagon or catechola- 
mines. Treatment of rat hepatocytes with the phos- 
phodiesterase inhibi tor  3- isobutyl- l -methyl-  
xanthine increased cAMP levels, but did not affect 
TABLE III 
EFFECT OF HORMONES AND CYCLIC AMP ON AMINO ACID TRANSPORT KINETIC CONSTANTS 
Tissue or cell type Effector Observed effect Reference 
Primary effects on Vm~ , 
1. Liver slices 
2. Hepatocytes 
3. Hepatocytes in culture 
4. Isolated perfused liver 





10. Chick embryo 
I I. Mammary gland 
Primary effects on K,, 
1. Hepatocytes in culture 
2. Diaphragm 
3. Human fibroblasts 
4. Lung 
Glucagon Increased Vma x 173 
Glucocorticoids Increased Vma x 114, 115 
Insulin Increased Vm~ x 71, 72 
Catecholamines Increased Vm~ ~ 114, 174 
Glucagon Increased Vm~ x 72 
Glucagon Increased Vma x 174, 175 
Insulin Increased Vm~ x 176 
Glucocorticoids ~ Increased Vm~ ~ 177 
Growth hormone Increased Vm~ ~ 165 
(with a smaller 
increase in K m) 
Glucocorticoids Decreased Vm~ x 119, 174, 178 
Insulin b Increased Vm~ 118 
(with a smaller 
increase in K,,)  
cAMP Increased Vm~ ~ 179 
Glucocorticoids Decreased Vm~ ~ 180 
Insulin Increased Vm,,x 75, 181 
cAMP Increased Vm~ x 182 
Glucocorticoids Decreased Vm~ 183 
Estrogen Increased Vma ~ 34, 184 
Insulin Increased Vm~ 185 
Insulin Increased V . ~  73, 186 
Insulin Increased Vm~ ~ 133 
Glucagon Decreased K m 175, 177 
(with a smaller 
increase in Vm~x) 
Catecholamines Decreased K m 104 
Insulin Decreased K m 125, 187 
Glucocorticoids Decreased K,n 188 
Insulin Decreased K,, 79, 93 
Insulin Decreased K m 168 
Effect was only observed after the cells were treated with either glucagon [177] or catecholamine [104]. See text for discussion. 
h Effect was only observed after the cells were treated with glucocorticoid [118]. See text for discussion. 
amino acid transport [70]. Pariza and co-workers 
[104] reported that whereas both epinephrine and 
isoproterenol increased cellular cAMP, only the 
epinephrine treatment increased AIB uptake. Fur- 
thermore, the relationship between changes in 
cAMP levels and changes in amino acid uptake in 
response to hormone treatment in several 
hepatoma lines also suggests that increases in 
cAMP are neither necessary nor sufficient to 
account for the hormonal regulation of transport 
observed in these cells [ 105,106]. 
Using the calcium ionophore A23187, Kelley 
and colleagues [107] observed that in calcium-de- 
pleted cells glucagon did not stimulate AIB up- 
take, despite a concomitant six- to sevenfold in- 
crease in cellular cAMP. Addition of calcium to 
cells previously depleted of the ion by treatment 
with A23187 increased both the basal and 
hormone-stimulated transport [107]. Furthermore, 
when calcium-depleted hepatocytes were placed in 
calcium-containing medium, the glucagon stimula- 
tion of AIB transport increased with increasing 
calcium ion concentrations, but the hormone-de- 
pendent cAMP production declined [107]. The 
authors concluded that glucagon induction of 
hepatic amino acid uptake depends on mobiliza- 
tion of calcium either directly or through changes 
in cellular cAMP. 
IVD. Effects of hormones on the kinetics of amino 
acid transport 
Many studies of the hormonal stimulation of 
amino acid uptake have included determination of 
the kinetic parameters for transport. As discussed 
elsewhere [108,109], restraint must be exercised in 
the interpretation of kinetic data based on the 
enzymological definitions of the kinetic constants 
K m and Irma x. Unless the binding component has 
been isolated, the K m calculated for a transport 
substrate should not be taken as the dissociation 
constant of the substrate-carrier complex [108,110]. 
Moreover, the multiplicity of transport systems 
with overlapping specificities in most cell types 
makes the assignment of g m values to individual 
transport routes difficult (see Fig. 4.11 in Ref. 
108). 
Table III lists the reported effects of hormones 
on the kinetics of amino acid transport. In most 
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cases, whether the predominant effect of hormone 
treatment is an increase or decrease in uptake, the 
change is reflected by a corresponding change in 
the Vm~ ~. A few exceptions to this pattern are 
noted in Table III. 
IVE. Effects of glucocorticoids on amino acid trans- 
port 
The enhancement of the activity of other 
hormones by glucocorticoids has been termed per- 
missive because the glucocorticoid appears to al- 
low or permit the hormone induction [ 111 ]. Potter 
and co-workers [104] have reported that gluco- 
corticoids acted permissively on the epinephrine 
stimulation of hepatic AIB uptake, increasing the 
Vma x. These investigators also described the per- 
missive effect of glucocorticoids on the stimulation 
of amino acid transport by glucagon and proposed 
a model to explain their results [112]. The basic 
premise of the model is that glucocorticoids main- 
tain a high level of System A in an inactive form. 
Glucagon is thought to activate this inactive form 
of the transport system. Because dexamethasone 
showed the permissive effect with cAMP as well as 
with glucagon [112], the action of the gluco- 
corticoid was proposed to be at a step subsequent 
to the glucagon receptor. Potter and colleagues 
[112] proposed that glucagon may also block the 
degradation or inactivation of the active transport 
system. 
LeCam and Freychet have also investigated the 
stimulation of amino acid transport by glucagon 
[65,72,73] and epinephrine [113,114], but in freshly 
isolated hepatocytes rather than cultured cells. In 
contrast to the results of Potter and co-workers, 
LeCam and Freychet found that for freshly iso- 
lated cells: (1) glucocorticoids stimulated AIB up- 
take in the absence of other hormones [114,115]; 
(2) the effects of epinephrine [113,114] and the 
glucocorticoid were additive (that is, the gluco- 
corticoid was not permissive); (3) glucagon [72] 
and epinephrine [113,114] caused an increase in 
Vma x rather than a decrease in K m ;  and, (4) isopro- 
terenol stimulated AIB uptake [113,114]. In agree- 
ment with the results of Potter, hepatocytes iso- 
lated from adrenalectomized rats, whether assayed 
as freshly isolated suspensions [116] or as primary 
cultures [117], showed a significantly lower re- 
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sponse to glucagon. Interestingly, these cells are 
also less competent to respond to induction of 
transport by insulin or amino acid starvation [ 117]. 
Gelehrter and colleagues showed that in HTC 
cells a 2-h dexamethasone treatment caused a de- 
cline in AIB uptake, reflected by a 25% decrease in 
Vma x [118,119], in striking contrast with the in- 
creased uptake seen by LeCam and Freychet in 
freshly isolated hepatocytes [115]. In addition, the 
continued exposure of HTC cells to dexametha- 
sone for 18 h resulted in a concomitant increase 
the in K m of AIB uptake [118,119]. When HTC 
cells were exposed to dexamethasone for 18 h to 
maximally inhibit transport and then incubated 
with both dexamethasone and insulin, the uptake 
of AIB was restored to about 75% of that in cells 
not treated with dexamethasone. The insulin-de- 
pendent restoration of AIB transport in the dex- 
amethasone-treated cells resulted in a fourfold in- 
crease in Vm, x and a twofold decrease in K m 
[118,119]. This insulin-dependent restoration of 
transport may be similar to the permissive effect 
of glucocorticoids on glucagon-stimulated trans- 
port observed by Potter and co-workers [112], 
described above. 
IVF. Possible mechanisms of the hormonal stimula- 
tion of amino acid transport 
That such a wide variety of hormones stimulate 
amino acid transport suggests that there are several 
different routes by which the hormone-mediated 
stimulation of transport can occur. Possibilities to 
be considered below include the de novo synthesis 
of transport carriers, alterations in the membrane 
potential, and the post-translational conversion of 
inactive transport carriers to an active form. 
IVF-1. De novo synthesis of transport carriers 
The role of de novo protein synthesis in the 
stimulation of amino acid transport has been 
studied in several tissues. Most of these studies 
employed protein synthesis inhibitors such as 
puromycin or cycloheximide, or blockers of RNA 
synthesis such as actinomycin D. These inhibitors 
of macromolecular synthesis usually significantly 
alter the intracellular pools of amino acids, which 
in turn may affect System A activity both by 
trans-inhibition and by adaptive regulation, as dis- 
cussed above. These changes in intracellular amino 
acids must be taken i n t o  account when mac- 
romolecular synthesis inhibitors are used to study 
transport regulation. 
Some of the initial work in this area of research 
showed that puromycin inhibited the stimulation 
of protein synthesis by insulin in muscle tissue 
without blocking its enhancement of amino acid 
uptake during the first 3 h of hormone treatment 
[120-122]. Similar effects of growth hormone on 
isolated rat diaphragm have been reported 
[123,124]. In contrast, incubation of the muscle 
tissue with puromycin or actinomycin D for peri- 
ods longer than 3 h blocked the insulin-induced 
transport as well [125]. Incubation with the inhibi- 
tors for longer than 3 h also resulted in a decline 
in the basal uptake rate of AIB [126-128], ena- 
bling Elsas and co-workers to estimate a half-life 
of the transport system of about 3.5 h. The decay 
of the basal activity of System A in isolated rat 
hepatocytes treated with cycloheximide yields an 
estimated half-life of about 3 h (Kilberg, M.S., 
unpublished data). Collectively, the results re- 
ported to date are consistent with the proposal 
that amino acid transport can be enhanced by 
both protein synthesis-dependent and protein 
synthesis-independent mechanisms [128]. Using 
both cycloheximide and actinomycin D, Guidotti 
and his associates [129,130] concluded that the 
insulin stimulation of amino acid uptake in chick 
embryo heart cells involves regulation at the level 
of translation rather than transcription. 
The role of protein synthesis might not be to 
generate increased amounts of membrane trans- 
port components, but rather to alter the levels of 
factors that regulate transport activity. One possi- 
ble mechanism by which this regulation could 
occur is through the degradation of one or more 
essential components of the transport system. 
Guidotti and co-workers [129] concluded that in 
chick embryo heart cells insulin stimulates the 
synthesis of new proteins necessary for transport 
activity and also protects the existing transport 
components from degradation. It has been pro- 
posed that the dexamethasone-induced inhibition 
of System A transport in HTC cells may result 
from an increased synthesis of a component in- 
volved in the degradation of the transport system 
[ 131,132]. Similarly, glucagon has been suggested 
to increase hepatic System A activity by slowing 
the turnover rate of that system [70,112]. The 
stimulatory and protective action of the hormone 
on transport may thus result from an increased 
rate of degradation of a component that in- 
activates the transport system. 
In several tissues the stimulation of amino acid 
transport has been shown to be independent of 
protein synthesis, either by an insensitivity to in- 
hibitors or by an induction too rapid to involve de 
novo protein synthesis. Examples include the in- 
sulin effects in mammary tissue [133], diaphragm 
[121,124], and frog skeletal muscle [134]; the 
growth hormone-mediated enhancement in di- 
aphragm [123]; a portion of the insulin and 
glucagon stimulation in rat hepatocytes [135]; and 
the short-term thyroid effects on System L activity 
in cartilage tissue [69,136]. Edmondson and 
Lumeng [135] have shown that glucagon stimulates 
System A transport in freshly isolated rat hepato- 
cytes without a significant lag period, a result 
obtained by others with isolated perfused liver 
[64,99,100,137] and hepatocytes in suspension 
[65,73], but not with primary cultures of hepato- 
cytes ([70], Schwass, D.E. and Christensen, H.N., 
personal communication). Furthermore, in the 
studies of Edmondson and Lumeng [135] the ini- 
tial 15-30-min period of stimulation by glucagon 
was not altered by treatment with cycloheximide, 
whereas the increase in transport activity after 30 
min was abolished by this inhibitor. Similar results 
have been obtained after treatment of the cells 
with cAMP rather than glucagon [138]. These re- 
suits suggest the existence of two separate phases 
of hormone stimulation of System A in hepato- 
cytes, an initial period independent of de novo 
macromolecular synthesis and a second phase de- 
pendent on protein synthesis. 
IVF-2. Alterations in membrane potential 
There are several possible mechanisms by which 
amino acid transport activity might be increased 
independent of protein synthesis. An increase in 
the magnitude of the transmembrane electrochem- 
ical gradient could produce an increase in the 
transport by System A as a result of the depen- 
dence of this system on the flow of sodium ions. A 
hormone could hyperpolarize the cell membrane 
by increasing the membrane permeability to potas- 
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sium ion, by decreasing the membrane permeabil- 
ity to sodium ion, or by increasing the activity of 
the electrogenic sodium-potassium ATPase [139]. 
Of the polypeptide hormones that alter the 
membrane potential, insulin and glucagon have 
been studied in the greatest detail. Insulin has 
been reported to hyperpolarize the membrane in 
several cell types [139-141]. Despite a conflicting 
report [142], Zierler and Rogus [143] postulated 
that the rapid insulin-mediated hyperpolarization 
in adipocytes contributes to the driving force for 
insulin-stimulated glucose transport. Friedmann 
and Dambach [144] observed an increase in mem- 
brane potential in rat liver from 39.0 to 47.2 mV 
after glucagon treatment, and similar results have 
been reported by Graf and Peterson [145]. Addi- 
tion of insulin resulted in an antagonistic effect 
such that the glucagon stimulation of membrane 
potential was abolished. 
Edmondson and Lumeng [135] suggested that 
the glucagon-induced System A uptake is the re- 
sult of a concomitant increase in membrane poten- 
tial based on the observed temporal similarities 
between glucagon-stimulated transport and in- 
creased transport caused by an artificially created 
increase in the membrane potential. Villereal and 
Cook [146] have implicated cell membrane hy- 
perpolarization in the serum stimulation of amino 
acid transport in human fibroblasts, which was 
accompanied by a decrease in K m rather than an 
increase in the Vma x of the transport system. As 
Villereal and Cook pointed out [146], their results 
support the 'velocity model' proposed by Geck 
and Heinz [147], which states that the amino acid- 
sodium ion-carrier ternary complex is the charged 
form and that the K m is a measure of the availabil- 
ity of transport sites at the inner and outer surfaces 
of the membrane. 
The difficulty in implicating membrane poten- 
tial in the mediation of hormonal regulation of 
transport is in explaining the specificity of the 
regulation. Although it is not clear that a change 
in membrane potential would affect every 
sodium-dependent amino acid transport system 
equally, presumably a hormone-induced mem- 
brane hyperpolarization would cause some in- 
crease in uptake by all of the sodium-dependent 
transport systems, including Systems ASC and N. 
Neither of these systems has been shown to be 
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affected by a variety of hormones [65,72,129]. If 
hyperpolarization of the plasma membrane is to be 
considered as an explanation for the hormonal 
regulation of System A activity, the specificity of 
the response must be adequately explained. 
I VF-3. Activation of transport carriers 
Other possible mechanisms for the hormone- 
mediated stimulation of amino acid transport in- 
clude the activation of inactive carriers or the 
recruitment of cryptic membrane transport car- 
riers. Potter and associates [112] proposed a model 
in which glucocorticoids increase the production 
of an inactive form of the carrier, possibly by 
regulation at the level of transcription. This step 
would be dependent on protein synthesis, but 
would not result in a detectable increase in trans- 
port activity. Glucagon is postulated to enhance 
transport activity by then causing an increased 
conversion of the inactive carrier to its active form 
[112]. In theory, this second step could be either 
dependent or independent of de novo protein 
synthesis, although most of the induction of trans- 
port by glucagon is cycloheximide-sensitive [135]. 
Protein synthesis-independent stimulation of 
transport might occur by post-translational mod- 
ification of a protein, perhaps by the phosphoryla- 
tion of a protein component of the transport sys- 
tem. Recently, both glucagon- and insulin-stimu- 
lated changes in membrane protein phosphoryla- 
tion were documented for the rat hepatocyte 
[148,149]. Changes in AIB transport by plasma 
membrane vesicles isolated from mouse fibroblasts 
have been observed after induction of changes in 
membrane protein phosphorylation [150]. In these 
studies, the addition of cAMP-dependent protein 
kinases resulted in increased phosphorylation of 
several membrane proteins and a concomitant de- 
crease in AIB uptake [150]. In contrast, the addi- 
tion of cAMP alone stimulated AIB uptake. 
Similarly, much recent interest has centered on 
the possibility that certain hormones act to stimu- 
late transport by recruiting cryptic transport car- 
riers from internal membranes to the plasma mem- 
brane of the cell. In both rat adipocytes [151,152] 
and rat diaphragm [153] it has been demonstrated 
that the treatment with insulin results in an in- 
crease in the number of glucose transport carriers 
in the plasma membrane fraction, as assayed by 
the binding of cytochalasin B, and a correspond- 
ing decrease in the number of transport carriers in 
the microsomal fraction. This translocation of glu- 
cose transporters from an intracellular membrane 
pool has been shown to be reversible [154], and to 
be blocked by uncouplers of oxidative phosphory- 
lation but not by inhibitors of protein synthesis 
[155]. A similar recruitment of cryptic transport 
carriers should be considered as a possible mecha- 
nism of the regulation of amino acid transport in 
rat hepatocytes [ 156,157]. This type of mechanism 
will undoubtedly be the focus of much future work 
on the hormonal regulation of amino acid trans- 
port. 
V. Concluding remarks 
It is well established that neutral amino acid 
transport exhibits both adaptational and hormonal 
regulation in animal cells. Adaptation of transport 
activities to meet the nutritional requirements of 
the cell has been demonstrated in a large number 
of cell types. Most studies have focused on trans- 
port System A, which has been shown to increase 
in activity in response to complete amino acid 
starvation and to treatment with hormones includ- 
ing catecholamines, steroids, growth factors, and 
the polypeptide hormones. Recent work has shown 
that other transport systems are under regulatory 
controls. Transport System L has been dem- 
onstrated to increase in activity in response to 
leucine limitation in Chinese hamster ovary cells. 
This system is also regulated in primary cultures of 
rat hepatocytes, although this process is not well 
understood. Finally, System N has been seen to 
increase in activity in response to complete amino 
acid deprivation in normal rat hepatocytes and rat 
hepatoma cells. 
The increased rates of amino acid transport by 
System A observed after amino acid starvation or 
hormone treatment have in almost all cases been 
attributed to increased numbers of membrane 
transport carriers, reflected by increased Vma ~ val- 
ues for transport. It has similarly been concluded 
that the regulation of System L activity is through 
changes in the number of transport carriers. Dif- 
ferent primary points of control have been pos- 
tulated for Systems A and L, however. There is 
substantial evidence from several cell types that 
the major  regulatory site for System A is at the 
level of t ranscript ion.  In  contrast,  it has been 
suggested that for the regulat ion of System L 
activity in Chinese hamster  ovary cells the pr imary 
poin t  of control  is at the t ranslat ional  level. For  
System A, an increase in the n u m b e r  of t ransport  
carriers may result pr imari ly from increased rates 
of t ranscr ipt ion of a carrier-specific gene leading 
to accelerated de novo synthesis of carrier pro- 
teins. For  System L, on the other hand,  an increase 
in the number  of carriers may result pr imari ly 
from increased rates of t ranslat ion of carrier- 
specific m R N A ,  or perhaps even from the recruit- 
men t  of existing carriers from intracellular mem- 
branes.  The recrui tment  of cryptic t ransport  car- 
riers has been amply demonst ra ted  in the insul in  
s t imula t ion  of glucose t ransport  in rat adipocytes 
and  diaphragm, and may well be involved in the 
mechanism of the s t imulat ion of amino  acid trans- 
port  by hormones  as well. 
Genet ic  approaches should be useful in eluci- 
dat ing the mechanisms of regulation of the amino  
acid t ransport  systems. Some mutan t s  have been 
isolated that appear to be defective in the regula- 
t ion of System L activity in Chinese hamster  ovary 
cells. Addi t ional  t ransport  regulatory mutan t s  
should yield impor tan t  informat ion  about  the nor- 
mal  regulatory mechanisms in animal  cells. 
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